Two Sigma Investments’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-10,601
| Closed | -$231K | – | 3203 |
|
2024
Q4 | $231K | Sell |
10,601
-588
| -5% | -$12.8K | ﹤0.01% | 2760 |
|
2024
Q3 | $306K | Buy |
11,189
+689
| +7% | +$18.9K | ﹤0.01% | 2597 |
|
2024
Q2 | $272K | Sell |
10,500
-27,471
| -72% | -$711K | ﹤0.01% | 2561 |
|
2024
Q1 | $1.14M | Buy |
+37,971
| New | +$1.14M | ﹤0.01% | 1816 |
|
2023
Q3 | – | Sell |
-7,517
| Closed | -$91.2K | – | 2930 |
|
2023
Q2 | $91.2K | Buy |
7,517
+1,806
| +32% | +$21.9K | ﹤0.01% | 2685 |
|
2023
Q1 | $72.6K | Sell |
5,711
-5,922
| -51% | -$75.3K | ﹤0.01% | 2633 |
|
2022
Q4 | $73.5K | Buy |
11,633
+3,442
| +42% | +$21.8K | ﹤0.01% | 2487 |
|
2022
Q3 | $185K | Sell |
8,191
-4,407
| -35% | -$99.5K | ﹤0.01% | 2078 |
|
2022
Q2 | $242K | Buy |
12,598
+2,734
| +28% | +$52.5K | ﹤0.01% | 2036 |
|
2022
Q1 | $458K | Sell |
9,864
-1
| -0% | -$46 | ﹤0.01% | 2026 |
|
2021
Q4 | $699K | Buy |
9,865
+967
| +11% | +$68.5K | ﹤0.01% | 1828 |
|
2021
Q3 | $1.04M | Sell |
8,898
-1,793
| -17% | -$209K | ﹤0.01% | 1673 |
|
2021
Q2 | $1.67M | Buy |
10,691
+798
| +8% | +$125K | ﹤0.01% | 1423 |
|
2021
Q1 | $1.87M | Sell |
9,893
-2,512
| -20% | -$476K | ﹤0.01% | 1300 |
|
2020
Q4 | $1.56M | Buy |
12,405
+707
| +6% | +$88.7K | ﹤0.01% | 1175 |
|
2020
Q3 | $1.27M | Buy |
11,698
+10,973
| +1,514% | +$1.19M | ﹤0.01% | 1086 |
|
2020
Q2 | $87K | Sell |
725
-346
| -32% | -$41.5K | ﹤0.01% | 1865 |
|
2020
Q1 | $108K | Buy |
+1,071
| New | +$108K | ﹤0.01% | 1719 |
|
2019
Q1 | – | Sell |
-1,145
| Closed | -$104K | – | 2186 |
|
2018
Q4 | $104K | Buy |
+1,145
| New | +$104K | ﹤0.01% | 1947 |
|